43 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
27 Feb 14
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
12:00am
Exhibit 99.1
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress
of the Japanese Society for Regenerative Medicine
VANCOUVER, BC … Nakamura, and its Chief Medical Officer, Dr. Kevin McElwee, will be presenting at the 13th Congress of the Japanese Society for Regenerative Medicine
6-K
REPCF
Replicel Life Sciences Inc.
2 Jul 12
Current report (foreign)
12:00am
Chief Scientific Officer Updates European Hair Research Society on RepliCel’s TS001-2009 First-in-man Clinical Trial
June 26, 2012 – Vancouver … results from the Company’s TS001-2009 first-in-man clinical study at the 16th meeting of the European Hair Research Society in Barcelona, Spain this past
6-K
REPCF
Replicel Life Sciences Inc.
22 Mar 11
Current report (foreign)
12:00am
and Associate Provost at the University of Toronto between 2003 and 2007.
In 2007, Dr. Challis was awarded The McLaughlin Medal from the Royal Society … Scientist Award from the Society for Gynaecologic Investigation (SGI). Currently, he holds the rank of University Professor Emeritus, University of Toronto
6-K
REPCF
Replicel Life Sciences Inc.
31 May 06
Current report (foreign)
12:00am
-San Nicolas-El Salvador. He is a member of the Society of Mining Engineers and has held notable positions in the Mexican mining community including … of the Society of Mining Engineers and has held notable positions in the Mexican mining community including National President of the Mexican Mining Engineers
6-K
EX-99.4
REPCF
Replicel Life Sciences Inc.
18 Aug 21
Current report (foreign)
12:20pm
University Graduate School of Medical Sciences in Nagoya Japan.
Dr. Morita was the President of the Japanese Society of Investigative Dermatology (2017 … -2020) and was Program Officer for the Research Center of Science Systems at the Japanese Society for the Promotion of Science (2016-2020). He was Editor
6-K
EX-99.1
cap8p
7 Oct 14
RepliCel Life Sciences Adds Industry Specialist to Management Team
12:00am
6-K
EX-99.3
af0y tjeo17k9wx
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.1
c3m7j8h2ixl7npzwe tf
12 Oct 21
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents
1:06pm
6-K
EX-99.1
xh06 lg5sdrbwptdz
12 Jul 13
Current report (foreign)
12:00am
6-K
EX-99.1
2c0zrc
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
6-K
EX-99.1
2ocuo9ora
23 Feb 15
RepliCel Submits Clinical Trial Application for its Dermatological Product
12:00am
6-K
EX-99.1
almx6mjipgc hvli
24 Sep 19
Current report (foreign)
1:49pm
6-K
EX-99.2
unp1i2y
12 Jul 13
Current report (foreign)
12:00am
6-K
vz0836 rz9d
3 Dec 04
Current report (foreign)
12:00am
20-F/A
zru ubmmr9
12 Jan 18
Annual report (foreign) (amended)
12:00am